1. Amadori S, Papa G, Avvisati G, Fenu S, Monarca B, Petu MC, Pulsoni A, Mandelli F (1984) Sequential combination of high-dose Ara-C (Hi DAC) and asparaginase (ASP) for the treatment of advanced acute leukemia and lymphoma. Leuk Res 8: 729–735
2. Amadori S, Meloni G, Petti MC, Papa G, Miniero R, Mandelli F (1989) Phase II trial of intermediate dose Ara-C (IDAC) with sequential mitoxantrone (MITOX) in acute myelogenous leukemia. Leukemia 3: 112–114
3. Arlin ZA, Sklaroff RB, Gee TS, Kempin SJ, Howard J, Clarkson BD, Young CW (1980) Phase I and II trial of 4′-(9-acridinyl-amino) methanesulfon-m-anisidide in patients with acute leukemia. Cancer Res 40: 3304–3306
4. Arlin ZA, Silver R, Cassileth P, Armentrout S, Gams R, Daghestani A, Coleman M, Schoch I, Dukart G (1985) Phase I–II trial of mitoxantrone in acute leukemia. Cancer Treat Rep 69: 61–64
5. Arlin ZA, Gaddipati J, Ahmed T, Mittelman A, Friedland M, Rieber E (1985) Treatment of acute leukemia with amsacrine and high-dose cytarabine. Cancer Treat Rep 69: 1001–1002